Navigation Links
Daiichi Sankyo Co, Ltd. Joins the National Cherry Blossom Festival in Washington D.C. as Centennial Celebration Committee Co-Chair
Date:3/4/2010

WASHINGTON, March 4 /PRNewswire/ -- Daiichi Sankyo has joined the National Cherry Blossom Festival as co-chair of the Centennial Celebration Host Committee, spearheading the efforts over the next several years to commemorate, in 2012, the 100-year anniversary of the gift of cherry blossom trees from Tokyo to Washington, D.C.

Daiichi Sankyo, a global leader in pharmaceutical innovation since 1899, has a unique connection to the exotic cherry blossoms that famously line the tidal basin in D.C. Nearly a century ago, a world-famous chemist and Daiichi Sankyo's first president, Dr. Jokichi Takamine, had a vision to create a bridge of friendship between the two cities.  As a long-time resident in the U.S., he realized this vision by orchestrating a gift of 3,000 cherry trees on behalf of Tokyo as a symbol of friendship between the two nations.  Today, the National Cherry Blossom Festival and cherry trees draw U.S. and international visitors to Washington each year and remain a symbol of international friendship.

As co-chair of the Host Committee for the National Cherry Blossom Festival, Daiichi Sankyo will work with Festival organizers for the next several years to shape the Centennial Celebration by providing ideas, resources and funding to plan for a spectacular 100-year celebration.  

"The gifting of the cherry trees was an international sign of friendship and serves as inspiration for our global philanthropic mission, which is dedicated to listening, learning and making contributions that have a real impact on people's lives," said Takashi Shoda, chief executive officer of Daiichi Sankyo Co., Ltd. "Through continued drug development and discovery of therapies that improve the quality of life for patients around the world, our company will continue building on the traditions and scientific legacy of our forefathers and their vision for international collaboration and friendship."

The annual blooming of cherry blossoms symbolizes the balance of East and West, beauty and strength, and eternal renewal amidst seasonal change – a perennial reminder of the gift of friendship between Japan and the United States.

"We are thrilled that Daiichi Sankyo is joining us to create a momentous, once-in-a-lifetime celebration for Washington, D.C. and the nation," said Diana Mayhew, president of the National Cherry Blossom Festival. "The Centennial Celebration will embrace the history and traditions that the Festival honors, while setting the stage for the next 100 years. With Daiichi Sankyo's commitment and active participation, 2012 will surely be an unforgettable year."

About the National Cherry Blossom Festival

The National Cherry Blossom Festival is Washington, D.C.'s and the nation's greatest springtime celebration.  The 2010 Festival, March 27April 11, includes three spectacular weekends and daily events featuring diverse and creative programming promoting traditional and contemporary arts and culture, natural beauty, and community spirit.  The 2010 Festival commemorates the 98th anniversary of the gift of the cherry blossom trees and the enduring friendship between United States and Japan.

About Daiichi Sankyo

A global pharma innovator, Daiichi Sankyo Company, Ltd., was established in 2005 through the merger of two leading Japanese pharmaceutical companies. This integration created a more robust organization that allows for continuous development of novel drugs that enrich the quality of life for patients around the world. Areas of central focus for Daiichi Sankyo research and development are thrombotic disorders, malignant neoplasm, diabetes mellitus, and autoimmune disorders. Equally important to the company are hypertension, hyperlipidemia or atherosclerosis and bacterial infections. For more information, visit www.daiichisankyo.com.

Daiichi Sankyo, Inc., headquartered in Parsippany, New Jersey, is the U.S. subsidiary of Daiichi Sankyo Company, Ltd. For more information on Daiichi Sankyo, Inc., please visit www.dsi.com.

For schedules and information visit www.nationalcherryblossomfestival.org or call the Festival hotline at (877) 44BLOOM.

SOURCE Daiichi Sankyo

Back to top

RELATED LINKS
http://www.daiichisankyo.com

'/>"/>

SOURCE Daiichi Sankyo
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Daiichi Sankyo Initiates Largest Single, Double-Blind, Randomized, Phase III Trial for Treatment and Prevention of Recurrent Venous Thromboembolism
2. Daiichi Sankyo Initiates Phase III Trial of Its Investigational Factor Xa Inhibitor, DU-176b, in Patients With Atrial Fibrillation
3. Daiichi Sankyo and Lilly Respond to Speculation on Status of Prasugrel New Drug Application
4. Daiichi Sankyo Announces Clinical Study Data for Oral Factor Xa Inhibitor DU-176b
5. FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel
6. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
7. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
8. Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
9. Bumrungrad - The Mayo Clinic of Asia - Joins MediBid.com as a Bidding Facility
10. Yvonne Verburgt Joins the Avrio Executive Team as Vice President of Business Development and Marketing
11. Lumetra PSO Joins Forces With iSOFT Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... India , March 23, 2017 ... growing ageing population, increasing diabetic population, accelerating economic growth and ... of this industry are higher life expectancy of ESRD patients, ... in emerging markets. However, the expansion of the market is ... ...
(Date:3/23/2017)... and INDIANAPOLIS , March ... LLY ) and the William Sansum Diabetes Center ... of Latino people affected by diabetes through enhanced research, ... of diabetes and cardiovascular disease bears a disproportionate weight ... ," said David Kerr , M.D., FRCPE, ...
(Date:3/23/2017)... , March 23, 2017   BioSpace , ... resource, has partnered with Indiana Biosciences Research Institute ... organizations and educational institutions to bring the state,s ... first-ever BioIndiana Hotbed map, an artistic representation of the ... was presented to Vice President Mike Pence , ...
Breaking Medicine Technology:
(Date:3/23/2017)... ... March 23, 2017 , ... A recent report from the ... teacher preparation programs. The NCTQ report suggests, based on a review of GPA and ... improve teacher quality in the U.S. It argues that this higher bar should be ...
(Date:3/23/2017)... ... , ... The IoT (Internet of Things) is revolutionizing the way the world ... businesses and individual consumers alike. Laboratories can maximize their profit margin by increasing ... $4 trillion to $11 trillion dollars by the year 2025. McKinsey expects the IoT ...
(Date:3/23/2017)... ... March 23, 2017 , ... Benefits ... an innovative mobile app and centralized benefits dashboard solving one of the top ... from multiple locations. For the first time, employees can access up-to-date information and ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... businesses of the greater Fort Collins area, has unveiled a collaboration with nonprofit ... involvement program. Donations to this worthy cause may now be made at ...
(Date:3/23/2017)... ... March 23, 2017 , ... ChenMed, a privately owned ... of the strategic executive team expansion needed to further optimize growth and performance. ... team,” says Christopher Chen, MD, ChenMed Chief Executive Officer. “George Wheeler and ...
Breaking Medicine News(10 mins):